Local Institution - 0222 is a clinical research site located in Cleveland, Ohio, United States 44195.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Local Institution - 0222 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma.
Sponsors: Bristol-Myers Squibb.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Local Institution - 0222 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Local Institution - 0222 has 1 clinical trials on record, with 1 currently active. Their work covers Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma.
Local Institution - 0222 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.